AI-powered pharma supply chain solution launches

Healthcare improvement company Premier has teamed up with a cognitive supply chain company, Pensiamo, to tackle drug supply chain with a new AI-powered solution.

The new solution, which was co-developed with healthcare provider and insurer UPMC, is called CognitiveRx. UPMC, which is a $20 billion, Pittsburgh-based healthcare provider, will be the first to implement the tool to better monitor market signals, predict risks related to shortages. UPMC also owns Pensiamo, and financial terms of the agreement were not disclosed.

The service predicts, manages and solves challenges with drug shortages, inflation, declining reimbursement and more related to the life sciences supply chain, according to a press release.

The emergence of the solution comes as other major pharma blockchain services are underway and other major healthcare companies are looking for pharma supply chain solutions. Recently, Walmart joined a blockchain group called MediLedger that aims to track and verify pharmaceuticals. The FDA is also working on a pilot program that tracks pharmaceuticals, trace inventory and helps ensure the integrity of products during the delivery process.

CognitiveRx uses machine learning to control and reduce pharmaceutical costs, using real-time signals to direct when to buy and recommend formulary strategies to buy the most advantageous products. The solution will also be offered to hospitals and health systems by Premier.

“CognitiveRx provides access to market exclusive recommendations that predict drug supply disruption risk, and support the rapid identification of clinical, purchasing and inventory solutions,” Jim Szilagy, president and CEO of Pensiamo and chief supply chain officer for UPMC, said in a statement. “We believe it will help UPMC and other healthcare organizations advance cost management and drug shortage mitigation strategies to further bend the cost curve.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”